Erschienen in:
01.02.2011
Overactive Bladder and Outlet Obstruction in Men
verfasst von:
Doreen E. Chung, Jaspreet S. Sandhu
Erschienen in:
Current Urology Reports
|
Ausgabe 1/2011
Einloggen, um Zugang zu erhalten
Abstract
Lower urinary tract symptoms (LUTS), overactive bladder, (OAB), and benign prostatic hyperplasia (BPH) are very commonly experienced in men. The mainstay of pharmacotherapy for OAB is the antimuscarinic class of drugs. There has been reluctance to prescribe these agents to men with BPH due to the risk of precipitating urinary retention. Several trials have supported the efficacy and safety of antimuscarinics in treating men with LUTS, alone, or in combination with α-blocker therapy. The combination of 5-α-reductase inhibitors with antimuscarinic agents or surgery are other effective treatments for men with BPH and OAB.